FDA and Web 2.0 – Is Social Media A Sand Box Or Regulatory Sand Trap? – MERCK

2:50pm -3:25pm

The emergence of social media, mobile medical applications, and “web 2.0” in the pharmaceutical space has created a new frontier in communication between corporations, medical professionals and patients.  But amid a quickly-changing technological landscape and developing guidance from the FDA, it can be tricky for pharmaceutical and healthcare companies to create a social media approach that is both useful to patients and in line with federal regulations.

From the ever-evolving social networking sites, such as Facebook and Twitter, to the increased development and marketing of mobile medical apps, pharmaceutical companies are developing creative strategies that take advantage of the latest technological advances, while having to navigate regulatory requirements, advertising laws, and patient privacy concerns.

Hear how Merck is navigating the social media landscape by:

  •  Working with the ever-changing regulatory landscape, as it pertains to web 2.0 including adaptation of old regulations to new technological approaches
  • Outlining the unique barriers and opportunities that drug companies experience in engaging social media outlets and marketing of mobile apps
  • Recognizing U.S. legal and regulatory issues pertaining to the use of social media in drug development and marketing
  • Understanding the policy positions and trends concerning FDA regulation of social media


Andrew Robertson, Director, Global Regulatory Affairs